About this trial
Participants will undergo LASIK surgery in one eye using ray tracing guided technology in one eye and LASIK surgery in the other eye using wavefront guided technology. We are comparing outcomes between the two technologies as measured by self reported quality of vision and quality of life outcomes using validated questionnaires before and after surgery. We will also be comparing outcomes between the two technologies including measurement of low contrast visual acuity,and best spectacle corrected visual acuity.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Single group
Treatments tested in this trial
Ray tracing guided LASIK surgery
DeviceLASIK
Treatment groups
Trial outcomes
Primary outcomes
Change in corrected distance visual acuity
The primary endpoint will be the gain in lines of corrected distance visual acuity (CDVA) at the postoperative month three follow-up compared with preoperative baseline.
Secondary outcomes
Change in 5 and 25% low contrast CDVA
Change in 5 and 25% low contrast best corrected visual acuity from preoperative to postoperative month three
Change in patient self reported quality of vision and life
Will compare preoperative quality of vision and quality of life as measured by the validated Patient Reported Outcomes With LASIK (PROWL) questionnaire to postoperative month three.
Corneal epithelial thickness changes
Measure corneal epithelial thickness maps preoperatively and compare changes at postoperative month three
Change in higher order aberrations
Will measure preoperative higher order aberrations using wavefront aberrometry and compare to postoperative month three measurements
Sponsors and contacts
Click on the lead sponsor to view all of their trials.